Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Frequency and outcome of cervical cancer prevention failures in the United States.

Raab SS, Grzybicki DM, Zarbo RJ, et al. Frequency and outcome of cervical cancer prevention failures in the United States. Am J Clin Pathol. 2007;128(5):817-24.

Save
Print
March 28, 2012
Raab SS, Grzybicki DM, Zarbo RJ, et al. Am J Clin Pathol. 2007;128(5):817-24.
View more articles from the same authors.

This AHRQ-funded study of cervical cancer screening results found a remarkably low incidence of missed malignancies. The authors analyzed Papanicolaou test results and the results of subsequent biopsies and found that the results were discordant in only 0.3% of cases, with most of these inconsistencies being clinically insignificant. Delayed diagnosis of cancer is a common cause of malpractice suits in ambulatory care. Although a prior study by Raab and colleagues found a higher overall error rate in anatomic pathology cancer diagnosis, this study documents that the US cervical cancer screening system appears to be very effective at preventing squamous cervical cancer. However, a systematic review of missed or delayed cancer diagnoses found that misdiagnosis of four common types of cancer—melanoma, as well as cancer of the breast, lung, or colon—remains common.

Save
Print
Cite
Citation

Raab SS, Grzybicki DM, Zarbo RJ, et al. Frequency and outcome of cervical cancer prevention failures in the United States. Am J Clin Pathol. 2007;128(5):817-24.